Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A clinical trial of Desidustat for indication of anemia (including dialysis and non-dialysis patients) caused by chronic kidney disease (CKD) .

Next Previous
X
Search
Trial Profile

A clinical trial of Desidustat for indication of anemia (including dialysis and non-dialysis patients) caused by chronic kidney disease (CKD) .

Status: Planning
Phase of Trial: Phase II

Latest Information Update: 22 Jan 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Desidustat (Primary)
  • Indications Anaemia
  • Focus Therapeutic Use
  • Sponsors China Medical System

    • Most Recent Events

    • 22 Jan 2021 New trial record
    • 19 Jan 2021 According to a China Medical System media release, it has been granted an approval for drug clinical trial issued on 18 January 2021 from the National Medical Products Administration of the Peoples Republic of China and agreed to carry out clinical trials for indication of anemia caused by chronic kidney disease (CKD) .

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top